These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 22699311)

  • 1. Regulation of the metastatic cell phenotype by sialylated glycans.
    Schultz MJ; Swindall AF; Bellis SL
    Cancer Metastasis Rev; 2012 Dec; 31(3-4):501-18. PubMed ID: 22699311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of β-Galactoside α2,6 Sialyltranferase 1 in Cancers.
    Lu J; Gu J
    Molecules; 2015 Apr; 20(5):7509-27. PubMed ID: 25919275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor cell N-glycans in metastasis.
    Laidler P; Lityńska A
    Acta Biochim Pol; 1997; 44(2):343-57. PubMed ID: 9360725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sialylated N-glycans in adult rat brain tissue--a widespread distribution of disialylated antennae in complex and hybrid structures.
    Zamze S; Harvey DJ; Chen YJ; Guile GR; Dwek RA; Wing DR
    Eur J Biochem; 1998 Nov; 258(1):243-70. PubMed ID: 9851715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sialylated β1, 6 branched N-glycans modulate the adhesion, invasion and metastasis of hepatocarcinoma cells.
    Yu X; Zhao Y; Wang L; Chen X; Su Z; Zhang H; Yuan Q; Wang S
    Biomed Pharmacother; 2016 Dec; 84():1654-1661. PubMed ID: 27847205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An immunohistochemical employer monoclonal antibodies against Le(a), sialyl Le(a), Le(x), and sialyl Le(x) antigens in primary colorectal, carcinomas and lymph node and hepatic lesions.
    Nakagoe T; Fukushima K; Hirota M; Kusano H; Ayabe H; Tomita M; Kamihira S
    J Gastroenterol; 1994 Apr; 29(2):129-38. PubMed ID: 7912139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycomic analysis of gastric carcinoma cells discloses glycans as modulators of RON receptor tyrosine kinase activation in cancer.
    Mereiter S; Magalhães A; Adamczyk B; Jin C; Almeida A; Drici L; Ibáñez-Vea M; Gomes C; Ferreira JA; Afonso LP; Santos LL; Larsen MR; Kolarich D; Karlsson NG; Reis CA
    Biochim Biophys Acta; 2016 Aug; 1860(8):1795-808. PubMed ID: 26721331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of tumor cell sialylation in pancreatic cancer progression.
    Marciel MP; Haldar B; Hwang J; Bhalerao N; Bellis SL
    Adv Cancer Res; 2023; 157():123-155. PubMed ID: 36725107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated Transcriptomics, Proteomics, and Glycomics Reveals the Association between Up-regulation of Sialylated N-glycans/Integrin and Breast Cancer Brain Metastasis.
    Peng W; Zhu R; Zhou S; Mirzaei P; Mechref Y
    Sci Rep; 2019 Nov; 9(1):17361. PubMed ID: 31758065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sialyl Lewis(a): a tumor-associated carbohydrate antigen involved in adhesion and metastatic potential of cancer cells.
    Ugorski M; Laskowska A
    Acta Biochim Pol; 2002; 49(2):303-11. PubMed ID: 12362971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal Stromal Cells Regulate Sialylations of N-Glycans, Affecting Cell Migration and Survival.
    Templeton K; Ramos M; Rose J; Le B; Zhou Q; Cressman A; Ferreyra S; Lebrilla CB; Fierro FA
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rho GTPase Rac1: molecular switch within the galectin network and for N-glycan α2,6-sialylation/O-glycan core 1 sialylation in colon cancer in vitro.
    André S; Singh T; Lacal JC; Smetana K; Gabius HJ
    Folia Biol (Praha); 2014; 60(3):95-107. PubMed ID: 25056432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycosylation: a hallmark of cancer?
    Vajaria BN; Patel PS
    Glycoconj J; 2017 Apr; 34(2):147-156. PubMed ID: 27975160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sialylation: an Avenue to Target Cancer Cells.
    Vajaria BN; Patel KR; Begum R; Patel PS
    Pathol Oncol Res; 2016 Jul; 22(3):443-7. PubMed ID: 26685886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer snap-shots: Biochemistry and glycopathology of O-glycans: A review.
    Sanji AS; J M; Gurav MJ; Batra SK; Chachadi VB
    Int J Biol Macromol; 2024 Mar; 260(Pt 1):129318. PubMed ID: 38232866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell surface glycan-lectin interactions in tumor metastasis.
    Rambaruth ND; Dwek MV
    Acta Histochem; 2011 Oct; 113(6):591-600. PubMed ID: 21501858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
    Pousset D; Piller V; Bureaud N; Monsigny M; Piller F
    Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic Sialylation in Transforming Growth Factor-β (TGF-β)-induced Epithelial to Mesenchymal Transition.
    Du J; Hong S; Dong L; Cheng B; Lin L; Zhao B; Chen YG; Chen X
    J Biol Chem; 2015 May; 290(19):12000-13. PubMed ID: 25809486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant glycosylation of αvβ3 integrin is associated with melanoma progression.
    Pocheć E; Bubka M; Rydlewska M; Janik M; Pokrywka M; Lityńska A
    Anticancer Res; 2015 Apr; 35(4):2093-103. PubMed ID: 25862865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-glycans modulate K(v)1.5 gating but have no effect on K(v)1.4 gating.
    Schwetz TA; Norring SA; Bennett ES
    Biochim Biophys Acta; 2010 Mar; 1798(3):367-75. PubMed ID: 19961828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.